PAR.AX
Paradigm Biopharmaceuticals Ltd
Price:
0.43
AUD
Volume:
1,265,957
Australia | Biotechnology
No data available for this ticker
PAR.AX Probability of Bankruptcy
The Probability of Bankruptcy of Paradigm Biopharmaceuticals Ltd (PAR.AX) is 0% . This number represents the probability that PAR.AX will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating PAR.AX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
PAR.AX - Historical Solvency Measures
to of
Page of
PAR.AX - ESG ratings
ESG ratings are directly linked to the cost of capital and PAR.AX's ability to raise funding, both of which can significantly affect the probability of Paradigm Biopharmaceuticals Ltd going bankrupt.
ESG Score
33.14
Environment Score
32.86
Social Score
54.58
Governance Score
11.97
| Returns | |
| Historical Returns (5 day) | -18.33% |
| Historical Returns (MTD) | -16.24% |
| Historical Returns (YTD) | 30.67% |
| Historical Returns (13 week) | 50.77% |
| Historical Returns (26 week) | 108.51% |
| Historical Returns (52 week) | 40% |
| Efficiency | |
| Asset Turnover | 0.18 |
| Receiveable Turnover | 4.86 |
| Gross Margin | 99.9% |
| Operating Margin | - |
| Pretax Margin | - |
| Net Margin | - |
| Return on Asset (ROA) | -161.96 |
| Return on Equity (ROE) | -203.64 |
| Return on Investments (ROI) | -202.12 |
| Price Metrics | |
| Market Cap (M) | 120.6 |
| Enterprise Value (M) | 96 |
| 52 Week High | 0.66 |
| 52 Week Low | 0.17 |
| Beta | 2.47 |
| Average Volume (10 day) | 1.9 |
| Average Volume (3 month) | 2.09 |
| Price / Earnings (P/E) | - |
| Price / Sales (P/S) | 32.3 |
| Earnings | |
| EPS | -0.19 |
| Revenue CAGR (5 year) | 14.97% |
| Risk | |
| Current Ratio | 7.22 |
| Quick Ratio | 6.83 |
PAR.AX - Peer Comparisons
| Ticker | Company Name | Beta | Probability of Bankruptcy |
| a |